DELFI Diagnostics

Saving Lives Through Early Cancer Detection

Baltimore, United States · Founded 2019 · $364.8M raised

Employees
51–200
Founded
2019
Business Model
B2B
Total Funding
$364.8M
Last Round
$34.3M Venture RoundDec 2025
Rounds
4

About

DELFI Diagnostics pioneers fragmentomics technology, analyzing cell-free DNA fragments from blood samples using advanced machine learning and next-generation sequencing for early cancer detection and monitoring. Their DELFI platform scans millions of data points to identify cancer signals with high sensitivity, supporting providers and pharma in treatment decisions. Developed by experts in genomics, AI, and cancer biology.

Summary

DELFI Diagnostics is an Artificial Intelligence company based in Baltimore, United States, founded in 2019. It has raised $364.8M in total across 4 rounds, most recently a $34.3M Venture Round round in Dec 2025. Investors include Menlo Ventures, OrbiMed and Samsara BioCapital.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Venture RoundVenture RoundDec 2025
$34.3M

Sign up to see all 4 rounds

Seed through Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

DELFI Diagnostics on Indexed.vc
<a href="https://indexed.vc/companies/delfi-diagnostics"><img src="https://indexed.vc/api/badge/company/delfi-diagnostics" alt="DELFI Diagnostics on Indexed.vc" width="260" height="76" /></a>